Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial (Q46393065)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q57978917)
(P304) 153-161
(P433) 1
(P478) 24
(P577) Thursday, January 1, 2009
(P921) (Q42824827)
(P1433) (Q15750941)
(P1476) "Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial" (language: en)
(P2093) Jacques P Brown
Richard L Prince
Chad Deal
Douglas P Kiel
Luiz H de Gregorio
Peyman Hadji
Lorenz C Hofbauer
Jose M Alvaro-Gracia
Huei Wang
Matthew Austin
Rachel B Wagman
Richard Newmark
Cesar Libanati
Javier San Martin
Henry G Bone
(P2860) (Q34140339)
(Q46677034)
(Q44995428)
(Q34642847)
(Q34003925)
(Q45126306)
(Q34485941)
(Q43435539)
(Q41697049)
(Q46473101)
(Q36514462)
(Q44306779)
(Q41649459)
(Q24311588)
(Q24682139)
(Q34656025)
(Q28298728)
(Q46551911)
(Q44587781)
(Q56622251)
(Q34009569)
(Q45201999)
(Q45261759)
(Q46133598)
(Q58971166)
(Q58868250)
other details
description scientific article

External Links